We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

INFY:NYSEInfosys Limited Analysis

Data as of 2026-05-25 - not real-time

$12.67

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Infosys reported a 21% YoY jump in Q4 profit and a 13.4% quarterly revenue increase, yet the cautious FY27 revenue guidance of 1.5‑3.5% triggered a near‑6% pre‑market drop in its ADRs. The stock trades at $12.67, comfortably above the computed support of $11.56 and below the $13.27 resistance, offering an upside potential of roughly 16% versus the DCF fair value of $14.19. Its forward P/E of 15.8 is well below the industry average of 39.5, and a 4.07% dividend yield with a 64% payout ratio underscores strong cash generation. Technical signals are mixed: the MACD histogram is positive and the line sits above the signal, suggesting short‑term bullish momentum, while the 20‑day SMA (12.39) sits below the 50‑day (13.07) and 200‑day (15.91) averages, confirming a longer‑term bearish trend. RSI at 49 is neutral, and volume is increasing, but 30‑day volatility remains high at 38% and beta is sub‑1, indicating modest market sensitivity. Fundamentally, the company delivers solid ROE (31%) and ROA (15%), maintains a healthy cash balance, and benefits from AI‑driven deal wins, supporting a view that the stock is undervalued despite near‑term sentiment pressure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings guidance dampens sentiment
  • Price near technical support with limited upside to resistance
  • Attractive dividend yield provides buffer

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Valuation gap versus industry peers
  • AI collaborations and large deal pipeline
  • Sustainable dividend and strong cash flow

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust ROE/ROA and consistent earnings generation
  • Undervaluation relative to DCF fair value
  • Strategic positioning in high‑growth digital and AI services

Key Metrics & Analysis

Financial Health

Revenue Growth6.60%
Profit Margin16.43%
P/E Ratio15.8
ROE31.44%
ROA15.09%
Debt/Equity9.83
P/B Ratio10.5
Op. Cash Flow$4.0B
Free Cash Flow$3.2B
Industry P/E39.5

Technical Analysis

TrendBearish
RSI48.9
Support$11.56
Resistance$13.27
MA 20$12.39
MA 50$13.07
MA 200$15.91
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair Value$14.19
Target Price$14.68
Upside/Downside15.87%
GradeUndervalued
TypeValue
Dividend Yield4.07%

Risk Assessment

Beta0.73
Volatility38.08%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.